From why it was created to whether it’s alive, here’s what to know about SpudCell, the latest advance in synthetic biology. By K. R. Callaway SpudCell is a synthetic cell made by scientists at the ...
Formulas are powerful tools for performing calculations and analyzing data in Excel. In this beginner’s guide, you’ll learn how to use formulas (with or without help from the Copilot AI assistant) and ...
Allison covers what hot startups are getting up to, and who’s financing them. She is also co-host of the weekly biotech podcast, “The Readout Loud.” You can reach Allison on Signal at AllisonDeAngelis ...
As the wave of in vivo CAR-T hype crests, Create Medicines is catching the swell with a $122 million series B meant to back its early pipeline of autoimmune and cancer candidates. Originally launched ...
Introducing the first in vivo data using RetroT, a first-in-class all-mRNA platform for stable gene delivery without viral components Demonstrating CREATE's leadership in in vivo immune cell ...
For years, one of the most powerful weapons against certain blood cancers, called CAR-T therapy, has required an elaborate process: Doctors extract a patient’s immune cells, ship them to a specialized ...
Bestseller Kleon (Steal Like an Artist) draws inspiration from his kids’ freewheeling approach to making art for these cheery, upbeat lessons on creativity. He writes that having rigid expectations of ...
Early in my career, a colleague and I made a shared commitment one summer to eat healthier. Salads. Smoothies. The full routine. Like many well-intentioned plans, our discipline began to fade after a ...
Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Holly Cummins discusses why "nothing is new ...
The Federal Reserve’s policy decisions in recent years have contributed to a worsening of economic inequality in America, and some of the central bank’s policymakers say it’s not a problem they can ...
Cell therapy company Link Cell Therapies is launching with $60 million and a mission to develop potent CAR-T therapies that go after a range of tumors while avoiding patients' healthy tissue. The ...
Steep learning curve. Slight pinging when typing. Strange quirks in setup require extensive troubleshooting. Lots of odd choices and bugs. Modules are difficult to use when tented. I really wanted to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results